Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | |
Gender (male vs. female) | 1.341 (0.691–2.603) | 0.386 | 0.406 (0.155–1.063) | 0.067 |
Age | 1.013 (0.985–1.043) | 0.360 | 1.018 (0.987–1.050) | 0.258 |
BMI | 0.961 (0.89–1.038) | 0.315 | ||
ALB | 1.015 (0.956–1.078) | 0.616 | ||
PALB | 0.382 (0.007–21.583) | 0.640 | ||
A/G | 1.002 (0.441–2.279) | 0.995 | ||
Hb | 0.998 (0.979–1.017) | 0.808 | ||
SCr | 1.024 (1.004–1.043) | 0.017* | 1.036 (1.013–1.060) | 0.002* |
SMA | 1 (0.99–1.01) | 0.989 | ||
SMI | 0.992 (0.96–1.025) | 0.632 | ||
PMA | 0.991 (0.935–1.049) | 0.746 | ||
PMI | 0.94 (0.784–1.128) | 0.507 | ||
Fat area | 1 (0.993–1.007) | 0.960 | ||
Sarcopenia (yes vs. no) | 1.061 (0.566–1.989) | 0.853 | 0.804 (0.376–1.719) | 0.574 |
Symptoms (yes vs. no) | 1.918 (1.025–3.589) | 0.042* | 1.300 (0.653–2.588) | 0.455 |
Histologic subtypes | 0.021* | 0.018* | ||
MLPS vs. WDLPS | 0.822 (0.244–2.767) | 0.454 (0.082–2.519) | ||
DDLPS vs. WDLPS | 1.451 (0.722–2.915) | 0.553 (0.144–2.120) | ||
PLPS vs. WDLPS | 38.718 (3.462–433.047) | 44.905 (3.462–582.423) | ||
FNCLCC | 0.158 | 0.093 | ||
Grade 2 vs. 1 | 1.749 (0.85–3.601) | 2.593 (1.010–6.660) | ||
Grade 3 vs. 1 | 2.074 (0.918–4.688) | 5.006 (0.930–26.946) | ||
Tumor burden | 0.991 (0.958–1.024) | 0.580 | ||
Combined-organ resection (yes vs. no) | 1.418 (0.651–3.088) | 0.379 | ||
Operation duration | 0.988 (0.781–1.249) | 0.918 | ||
Estimated blood loss | 1 (1–1) | 0.337 | ||
Blood transfusion (yes vs. no) | 1.33 (0.672–2.632) | 0.413 | ||
ICU stay (yes vs. no) | 1.895 (0.924–3.886) | 0.081 | 1.290 (0.535–3.110) | 0.57 |
Postoperative hospital stays | 1.02 (1.005–1.035) | 0.007 | 1.013 (0.995–1.031) | 0.167 |
Complication (yes vs. no) | 1.303 (0.69–2.46) | 0.415 |